In the 1980s, Lord, a manufacturing company that develops motion management devices, adhesives and sensing technologies, formed four separate foundations to support research efforts at Cleveland Clinic, Durham, N.C.-based Duke University, Boston-based MIT and Los Angeles-based USC. Since establishing the foundations, the organizations have received around $200 million each. Lord was purchased by Parker Hannifin Corp. for $3.6 billion in October.
The $1 billion donation will be split evenly among the four healthcare organizations. The deal is expected to be completed following required approvals, according to the news release emailed to Becker’s Hospital Review.
“Cleveland Clinic was founded on the ideal that innovation, research and teaching are integral components of patient care,” said Tom Mihaljevic, MD, CEO and president of Cleveland Clinic. “The Lord Foundation’s generous distributions allow us to continue tackling today’s most complex medical challenges, discovering the next breakthroughs and improving lives worldwide.”
More articles on innovation:
ProMedica innovation chief’s Nike-inspired advice for hospitals considering launching innovation efforts: ‘Just do it’
Physician viewpoint: Human innovation is a needed challenge to the healthcare status quo
Malcolm Gladwell: 3 reasons for the ‘lag’ between innovation and adoption
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
